Literature DB >> 8630397

HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease.

J Gaschet1, M A Treviño, M Cherel, R Vivien, A Garcia-Sahuquillo, M M Hallet, M Bonneville, J L Harrousseau, R Bragado, N Milpied, H Vié.   

Abstract

To study the repertoire and specificity of T lymphocytes infiltrating skin lesions during graft-versus-host disease (GVHD), we performed an exhaustive molecular and functional analysis of 146 T-cell clones derived from the skin of three patients undergoing an acute GVHD after allogeneic bone marrow transplantation (BMT) from HLA-mismatched related donors. Analysis of T-cell receptor (TCR) rearrangement and TCR chain junctional sequences demonstrated the presence of 11 distinct clones among the 64 derived from patient UPN1, six among the 58 derived from patient UPN2, and seven among the 24 derived from patient UPN3. Three of the 11 T-cell clones from patient UPN1, and all clones from patients UPN2 and UPN3 reacted with mismatched HLA alleles between the bone-marrow donor and recipient. Moreover, both HLA class I (HLA-A2 and -B27) and class II (HLA DP101, DP401, DP1301, DQ8, and DR402) molecules were recognized during this early antihost response. Finally, both TCR alpha and beta chains turned out to be extremely diverse, even within populations of clones derived from the same patient and directed against the same HLA allele. Taken together, these results indicate that any HLA mismatch is potentially targeted during early GVHD, and that the T-cell response at the onset of GVHD is both oligoclonal and highly diversified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630397

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

Authors:  J Gaschet; A Lim; L Liem; R Vivien; M M Hallet; J L Harousseau; J Even; E Goulmy; M Bonneville; N Milpied; H Vié
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.

Authors:  E J Claret; E P Alyea; E Orsini; C C Pickett; H Collins; Y Wang; D Neuberg; R J Soiffer; J Ritz
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Authors:  Katharina Fleischhauer; Bronwen E Shaw; Theodore Gooley; Mari Malkki; Peter Bardy; Jean-Denis Bignon; Valérie Dubois; Mary M Horowitz; J Alejandro Madrigal; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Stephen Spellman; Andrea Velardi; Elisabetta Zino; Effie W Petersdorf
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

Review 4.  Microchimerism and scleroderma: an update.

Authors:  Carol M Artlett
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

Review 5.  GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models.

Authors:  Nicholas J Hess; Matthew E Brown; Christian M Capitini
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

Review 6.  Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation.

Authors:  Ali Salman; Vishal Koparde; Charles E Hall; Max Jameson-Lee; Catherine Roberts; Myrna Serrano; Badar AbdulRazzaq; Jeremy Meier; Caleb Kennedy; Masoud H Manjili; Stephen R Spellman; Dayanjan Wijesinghe; Shahrukh Hashmi; Greg Buck; Rehan Qayyum; Michael Neale; Jason Reed; Amir A Toor
Journal:  Front Immunol       Date:  2018-10-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.